NCT00386516 2017-08-01
Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer
Galectin Therapeutics Inc.
Phase 2 Withdrawn
Galectin Therapeutics Inc.
Merck KGaA, Darmstadt, Germany
Shenzhen Kangzhe Pharmaceutical Co., Ltd.